Asymmetry Capital Management Announces Hiring of James Yin, Ph.D.

SAN FRANCISCO, Feb. 12, 2018 /PRNewswire/ -- Asymmetry Capital Management, L.P., an alternative asset management firm launched in 2013 by Scott Kay, is pleased to announce Mr. James Yin, Ph.D. has joined the Asymmetry Investment Team as an Analyst covering global therapeutics, based in the firm's San Francisco headquarters.  James has conducted research at the National Institutes of Health (NIH) and the University of Minnesota where he participated in breakthrough research to solve the atomic structure of the Rous Sarcoma Virus Intasome.  This research was published in the Journal Nature in February 2016.  

The Asymmetry team has over 42-years combined healthcare and healthcare investing experience across market cycles and macro events.  CIO Scott Kay notes, "James will strengthen our ability to research opportunities, long and short, in clinical-stage biotechnology, pharmaceutical companies and medical/life sciences technologies.  James' joining Asymmetry speaks to the opportunities he recognizes at our firm and we are gratified to be able to attract such exemplary talent."  Further Chris Zellner, COO of Asymmetry confirms, "Given the investment and business opportunities we see in 2018, this is an opportune time to expand our investment team and position the firm to accommodate capital inflows.  We look forward to James' contributions to our long track record of seeking to deliver capital protection and non-correlated returns to our institutional and private investors." 

About Asymmetry Capital Management, L.P.
Launched in 2013 by healthcare industry veteran Scott Kay, Asymmetry seeks to deliver absolute, risk-adjusted returns across market cycles by investing in a value-oriented, diversified, global portfolio of healthcare companies.  Asymmetry's goal is to generate returns on both long and short positions with moderate to low net exposure and low correlations to broad equity and healthcare-related indices.  The firm is also committed to trying to maximize positive and sustainable impacts on ESG (environment, social and governance) and responsible investing across its firm and funds.  Every Asymmetry employee has an economic interest in the firm and the Asymmetry Global Healthcare team has significant investments of their own invested alongside their clients.

SOURCE Asymmetry Capital Management, L.P.